Document is current
Any future updates will be listed below
-
Authors
Juto, Anna
Martin, Myriam
Björk, Albin
Padyukov, Leonid
Grönwall, Caroline
Antovic, Aleksandra
Bruchfeld, Annette
Gunnarsson, Iva
Blom, Anna M.
-
Funding
Funding for this research was provided by:
Stig and Gunborg Westman Fund
The Swedish Kidney Foundation
Alfred Österlunds Stiftelse
Anna-Greta Crafoords Stiftelse för Reumatologisk Forskning
the King Gustaf V 80-year Foundation
Stockholm County Council
The Swedish Rheumatism Association
Skåne University Hospital research funds
Skåne Regional Council
Karolinska Institute
- License Information
-
More Information
Article History
Received: 25 November 2024
Accepted: 10 February 2025
First Online: 5 March 2025
Declarations
:
: The collection of samples and population-based control subjects was performed according to the Declaration of Helsinki and approved by the Regional Ethical Review Boards in Stockholm (Dnr. 2019–02978, 2022–06448-02, 2023–07170-02, 2021–06355-02) and Lund (Dnr. 2014/409, Dnr. 2017/582) with all participants providing written consent to participate in the study.
: Not applicable.
: Anna M Blom is named as an inventor in a patent application including claims to use C4d as a biomarker.
